Sun Pharma arm launches breast cancer drug Palbociclib in India Ruchika Sharma11 Jan 2023 11:26 AM ISTMumbai: Sun Pharmaceutical Industries Limited toay announced that one of its wholly-owned subsidiaries has launched a novel anti-cancer drug,...
Medical Bulletin 9/January/2022 Isra Zaman9 Jan 2023 2:00 PM ISTHere are the top medical news for the day:Poor treatment by others may push sensitive people later to self harm: StudyNSSI behaviors include cutting...
Study finds B-cells can help predict HER2-positive breast cancer treatment response Isra Zaman9 Jan 2023 9:45 AM ISTUnderstanding why cancers respond, or don't respond, to therapy is crucial to effective and personalized treatment. In HER2-positive breast cancer,...
Medical Bulletin 6/January/2022 Isra Zaman6 Jan 2023 5:46 PM ISTHere are the top medical news for the day:Antibiotic residues in wastewater may be a threat to human health: StudyBacteria that become resistant to...
EMA validates marketing authorization application for Trodelvy for Pre-treated HR+/HER2- Metastatic Breast Cancer: Gilead Sciences Ruchika Sharma5 Jan 2023 4:30 PM ISTTrodelvy (sacituzumab govitecan-hziy) is a first-in-class Trop-2 directed antibody-drug conjugate.
Targeted therapy for children with high-risk Hodgkin lymphoma reduces relapse rates, shows trial Dr. Kamal Kant Kohli2 Jan 2023 9:45 AM ISTA targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large...
Metformin, promising adjuvant therapy for breast cancer treatment in obese postmenopausal women Dr Kartikeya Kohli27 Dec 2022 11:00 AM ISTEgypt: Metformin could be a safe and promising adjuvant therapy to letrozole in overweight/obese postmenopausal women with breast cancer, a recent...
USFDA nod to Alembic Pharma breast cancer injection Fulvestrant Ruchika Sharma26 Dec 2022 1:15 PM ISTFulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.
Drug interaction among tamoxifen and aromatase inhibitors tied to non adherence to Endocrine Therapy in breast cancer patients: JAMA Dr Nirali Kapoor25 Dec 2022 8:00 PM ISTEndocrine therapy (ET), which includes tamoxifen and aromatase inhibitors (AI) either alone or in combination with other agents, represents the...
Experts say patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement Ruchika Sharma10 Dec 2022 1:30 PM ISTUK: The rush to use AstraZeneca and Daiichi-Sankyo's drug Enhertu to treat certain types of breast cancer has far outpaced doctors' ability to...
Medical Bulletin 9/December/2022 Isra Zaman9 Dec 2022 5:57 PM ISTHere are the top medical news for the day:Yoga when complemented with regular exercise improves cardiovascular health and well-beingYoga is part of...
Capivasertib addition to fulvestrant improves progression-free survival in patients with advanced (HR)-positive breast cancer Isra Zaman9 Dec 2022 9:45 AM ISTPatients with HR-positive, HER2-negative breast cancer are commonly treated in the first line with an endocrine therapy-such as an aromatase...
